A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy

Journal of Infectious Diseases

Volumn 177, Issue 5, 1998, Pages 1339-1344

  Houghton, Raymond L ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIMONY; LEISHMANIA ANTIGEN; MEGLUMINE ANTIMONATE; PROTOZOON ANTIBODY; RECOMBINANT K 39; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MOLECULAR CLONING; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; VISCERAL LEISHMANIASIS;

EID: 0031949223     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515289     Document Type: Article

References (14)

1. De La Loma A, Martinez-Galliano E, Blazquez J, Alcala-Munoz A, Najera R. Leishmaniasis or AIDS? Trans R Soc Trop Med Hyg 1985;79:421-2.
2. World Health Organization. Report of the consultative meeting on HIV/Leishmania co-infections (Rome, September 1994). Geneva: WHO 1994.
3. Berenguer J, Moreno S, Cercenado E, Bernaldo de Quiros JCL, Garcia de la Fuenta A, Bouza E. Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1989;111:129-32.
4. Montalban C, Martinez-Fernandez R, Calleja JL, et al. Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989;2:655-60.
5. Condom MJ, Clotet B, Sirera G, Milla F, Foz M. Asymptomatic leishmaniasis in acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;111:767-8.
6. Matheron S, Cabie A, Parquin F, et al. Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement and secondary prophylaxis. AIDS 1992;62:238-40.
7. Gradoni L, Guaraldi G, Codeluppi M, Scalone A, Rivasi F. Gastric localization of leishmania in a patient with acquired immunodeficiency syndrome: a case report. APMIS 1995;103:25-8.
8. Jimenez MI, Gutierez-Sola B, Benito A, et al. Cutaneous Leishmania (L) infantum zymodemes isolated from bone marrow in AIDS patients. Res Revs Parasitol 1991;51:95-9.
9. Gramiccia M, Gradoni L, Troiani M. Heterogeneity among zymodemes of Leishmania infantum from HIV-positive patients with visceral leishmaniasis in South Italy. FEMS Microbiol Lett 1995;128:33-8.
10. WHO Expert Committee on Control of the Leishmaniases. WHO Tech Rep Ser 1990;793:139-58.
11. Gradoni L, Bryceson A, Desjeux P. Treatment of Mediterranean visceral leishmaniasis. Bull World Health Organ 1995;73:191-7.
12. Mantalban C, Calleja JL, Erice A, et al. Visceral leishmaniasis in patients infected with human immunodeficiency virus. Cooperative group for the study of leishmaniasis in AIDS. J Infect Dis 1990;21:261-70.
13. Gradoni L, Scalone A, Gramiccia M. HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections. Trans R Soc Trop Med Hyg 1993;87:94-6.
14. Rosenthal E, Marty P, Poizot-Martin I, et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 1995;89:159-62.